Benefits of vascular normalization are dose and time dependent--letter.

@article{Huang2013BenefitsOV,
  title={Benefits of vascular normalization are dose and time dependent--letter.},
  author={Yuhui Huang and Triantafyllos Stylianopoulos and Dan G Duda and Dai Fukumura and Rakesh K. Jain},
  journal={Cancer research},
  year={2013},
  volume={73 23},
  pages={
          7144-6
        }
}
Arjaans and colleagues reported that treatment with the anti-VEGF antibody bevacizumab hampers antibody uptake in an ectopic xenograft model of human ovarian cancer in mice ([1][1]). They found that bevacizumab decreased vessel number and increased pericyte coverage and concluded that treatment- 

Figures and Topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
SHOWING 1-10 OF 29 CITATIONS

3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy.

Huaming Yan, Mónica Romero-López, +5 authors John S Lowengrub
  • Cancer research
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND